People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Pharmaceuticals, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clovis Oncology, Inc. | — | Pharmaceuticals | Series D+ | $358.3M | $6.8B | 2013 |
| Opgen Inc | — | Biotechnology | Series B | $81.0M | $51.0M | 2009 |
| Trius Therapeutics Inc | — | Biotechnology | Series B | $49.3M | $1.2B | 2009 |
| Five Prime Therapeutics Inc | — | Biotechnology | Series B | $38.5M | $835.1M | 2014 |
| Veracyte, Inc. | — | Other Health Care | Series A | $22.1M | $258.2M | 2014 |
| Cero Therapeutics Holdings, Inc. | — | Pharmaceuticals | Series A | $16.4M | $17.9M | 2025 |
| Phaserx, Inc. | — | Biotechnology | Seed | $16.1M | $18.6M | 2009 |
| Helicos Biosciences Corp | — | Biotechnology | Series A | $10.0M | $361.5M | 2009 |
Brian G. Atwood at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian G. Atwood on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Atwood | 2 | 6 |
| Evan Jones | 2 | 4 |
| Steven Gillis | 1 | 23 |
| Brook Byers | 1 | 13 |
| Fred Cohen | 1 | 12 |
| Risa Stack | 1 | 9 |
| James C. Blair | 1 | 8 |
| David Kabakoff | 1 | 7 |
| Chris Ehrlich | 1 | 6 |
| Jonathan T. Lord | 1 | 5 |
| Lewis T. Williams | 1 | 5 |
| Jesse I. Treu | 1 | 5 |
| John Finn | 1 | 5 |
| Noubar B Afeyan | 1 | 5 |
| John D. Diekman | 1 | 4 |
| Samuel D. Colella | 1 | 4 |
| Jeffrey Stein | 1 | 4 |
| Misti Ushio | 1 | 4 |
| C Eric Winzer | 1 | 4 |
| Stanley N. Lapidus | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.